$BNGO One way of valuing stocks at a particular time is to try to figure out what the acquisition price could be within the next six months. For Bionano, each $1 billion in acquisition revenue = (roughly) $3 per share. So if you think Bionano could fetch $3 billion in the next six months, you think the current value is $9 per share. If you think (as I do) that we could get $6 billion sometime in the next six months, you think the current value is $18. I know it's hard to predict the acquisition value in the short (six month) term but it can be done from what we know about the needs of the industry, the special value Saphyr has for genetic research and diagnosis, the acquisition price others in the industry have received, the success of the management in previous endeavors, etc. Thinking about things in this way forces you to dwell less on the current market price and more on the underlying value.